Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surveillance of ischemic stroke recurrence after prescription of EFIENT tablets (prasugrel) - MID-NET Cohort Study
jRCT2031230288Active, not recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of prasugrel in ischemic stroke (2 cohorts), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Ischemic stroke recurrence. Started Jan 2009; status: active, not recruiting.
02
Drugs
prasugrel
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on jRCT2031230288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230288.